Estrella Immunopharma, Inc. (ESLA)
0.39
-0.02
(-4.90%)
USD |
NASDAQ |
Nov 06, 09:59
Estrella Immunopharma Market Cap : 16.78M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 17.65M |
| November 04, 2026 | 19.09M |
| November 03, 2026 | 17.99M |
| November 02, 2026 | 18.35M |
| October 30, 2026 | 27.51M |
| October 29, 2026 | 31.36M |
| October 28, 2026 | 35.36M |
| October 27, 2026 | 40.12M |
| October 26, 2026 | 39.54M |
| October 23, 2026 | 42.39M |
| October 22, 2026 | 31.28M |
| October 21, 2026 | 23.67M |
| October 20, 2026 | 17.21M |
| October 19, 2026 | 16.35M |
| October 16, 2026 | 18.50M |
| October 15, 2026 | 23.03M |
| October 14, 2026 | 13.68M |
| October 13, 2026 | 13.51M |
| October 12, 2026 | 14.14M |
| October 09, 2026 | 17.64M |
| October 08, 2026 | 17.97M |
| October 07, 2026 | 18.04M |
| October 06, 2026 | 18.46M |
| October 05, 2026 | 18.94M |
| October 02, 2026 | 20.14M |
| Date | Value |
|---|---|
| October 01, 2026 | 20.44M |
| September 30, 2026 | 20.08M |
| September 29, 2026 | 19.80M |
| September 28, 2026 | 18.56M |
| September 25, 2026 | 20.70M |
| September 24, 2026 | 20.27M |
| September 23, 2026 | 20.31M |
| September 22, 2026 | 20.87M |
| September 21, 2026 | 21.61M |
| September 18, 2026 | 22.77M |
| September 17, 2026 | 22.64M |
| September 16, 2026 | 27.54M |
| September 15, 2026 | 26.29M |
| September 14, 2026 | 27.35M |
| September 11, 2026 | 28.39M |
| September 10, 2026 | 28.96M |
| September 09, 2026 | 27.46M |
| September 08, 2026 | 27.55M |
| September 04, 2026 | 27.81M |
| September 03, 2026 | 27.58M |
| September 02, 2026 | 29.69M |
| September 01, 2026 | 29.76M |
| August 31, 2026 | 31.20M |
| August 28, 2026 | 30.34M |
| August 27, 2026 | 31.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.596B |
| Alnylam Pharmaceuticals, Inc. | 21.05B |
| Anika Therapeutics, Inc. | 226.84M |
| Savara, Inc. | 934.57M |
| Vericel Corp. | 2.607B |
Market Cap Related Metrics
| Price | 0.39 |
| Earnings Yield | -65.03% |